BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

732 related articles for article (PubMed ID: 20345453)

  • 1. Validity of the Greek EORTC QLQ-C30 and QLQ-BR23 for measuring health-related quality of life in breast cancer patients.
    Kontodimopoulos N; Ntinoulis K; Niakas D
    Eur J Cancer Care (Engl); 2011 May; 20(3):354-61. PubMed ID: 20345453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaires for Arabic-speaking Populations.
    Awad MA; Denic S; El Taji H
    Ann N Y Acad Sci; 2008 Sep; 1138():146-54. PubMed ID: 18837895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life of breast cancer patients in Taiwan: validation of the Taiwan Chinese version of the EORTC QLQ-C30 and EORTC QLQ-BR23.
    Chie WC; Chang KJ; Huang CS; Kuo WH
    Psychooncology; 2003; 12(7):729-35. PubMed ID: 14502597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring breast cancer-specific health-related quality of life in South Asia: psychometric properties of the Sinhala version of the EORTC QLQ-BR23.
    Jayasekara H; Rajapaksa LC; Brandberg Y
    Qual Life Res; 2008 Aug; 17(6):927-32. PubMed ID: 18500576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Mexican-Spanish version of the EORTC QLQ-C30 and BR23 questionnaires to assess health-related quality of life in Mexican women with breast cancer.
    Cerezo O; Oñate-Ocaña LF; Arrieta-Joffe P; González-Lara F; García-Pasquel MJ; Bargalló-Rocha E; Vilar-Compte D
    Eur J Cancer Care (Engl); 2012 Sep; 21(5):684-91. PubMed ID: 22329843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychometric properties of the simplified Chinese version of the EORTC QLQ-BR53 for measuring quality of life for breast cancer patients.
    Wan C; Tang X; Tu XM; Feng C; Messing S; Meng Q; Zhang X
    Breast Cancer Res Treat; 2007 Oct; 105(2):187-93. PubMed ID: 17221159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients.
    Cankurtaran ES; Ozalp E; Soygur H; Ozer S; Akbiyik DI; Bottomley A
    Eur J Cancer Care (Engl); 2008 Jan; 17(1):98-104. PubMed ID: 18181898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
    Guzelant A; Goksel T; Ozkok S; Tasbakan S; Aysan T; Bottomley A
    Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability and validity of Amharic version of EORTC QLQ-C30 and QLQ-BR23 modules for assessing health-related quality of life among breast cancer patients in Ethiopia.
    Gadisa DA; Gebremariam ET; Ali GY
    Health Qual Life Outcomes; 2019 Dec; 17(1):182. PubMed ID: 31830992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability and validity of the Greek QLQ-C30 and QLQ-MY20 for measuring quality of life in patients with multiple myeloma.
    Kontodimopoulos N; Samartzis A; Papadopoulos AA; Niakas D
    ScientificWorldJournal; 2012; 2012():842867. PubMed ID: 22919356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress.
    Browall M; Kenne Sarenmalm E; Nasic S; Wengström Y; Gaston-Johansson F
    J Pain Symptom Manage; 2013 Jul; 46(1):131-41. PubMed ID: 23195392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity, reliability and understanding of the EORTC-C30 and EORTC-BR23, quality of life questionnaires specific for breast cancer.
    Michels FA; Latorre Mdo R; Maciel Mdo S
    Rev Bras Epidemiol; 2013 Jun; 16(2):352-63. PubMed ID: 24142007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the Mexican Spanish version of the EORTC C30 and STO22 questionnaires for the evaluation of health-related quality of life in patients with gastric cancer.
    Oñate-Ocaña LF; Alcántara-Pilar A; Vilar-Compte D; García-Hubard G; Rojas-Castillo E; Alvarado-Aguilar S; Carrillo JF; Blazeby JM; Aiello-Crocifoglio V
    Ann Surg Oncol; 2009 Jan; 16(1):88-95. PubMed ID: 18979141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The EORTC QLQ-CX24 cervical cancer-specific quality of life questionnaire: psychometric properties in a South Asian sample of cervical cancer patients.
    Jayasekara H; Rajapaksa LC; Greimel ER
    Psychooncology; 2008 Oct; 17(10):1053-7. PubMed ID: 18203241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26.
    Fitzsimmons D; Kahl S; Butturini G; van Wyk M; Bornman P; Bassi C; Malfertheiner P; George SL; Johnson CD
    Am J Gastroenterol; 2005 Apr; 100(4):918-26. PubMed ID: 15784041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the EORTC QLQ-C30 and EORTC QLQ-H&N35 in patients with laryngeal cancer after surgery.
    Singer S; Wollbrück D; Wulke C; Dietz A; Klemm E; Oeken J; Meister EF; Gudziol H; Bindewald J; Schwarz R
    Head Neck; 2009 Jan; 31(1):64-76. PubMed ID: 18972411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
    Greimel ER; Kuljanic Vlasic K; Waldenstrom AC; Duric VM; Jensen PT; Singer S; Chie W; Nordin A; Bjelic Radisic V; Wydra D;
    Cancer; 2006 Oct; 107(8):1812-22. PubMed ID: 16977652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients.
    Demirci S; Eser E; Ozsaran Z; Tankisi D; Aras AB; Ozaydemir G; Anacak Y
    Asian Pac J Cancer Prev; 2011; 12(5):1283-7. PubMed ID: 21875283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer quality of life questionnaire cervical cancer module.
    Shin DW; Ahn E; Kim YM; Kang S; Kim BG; Seong SJ; Cha SD; Park CY; Yun YH
    Oncology; 2009; 76(3):190-8. PubMed ID: 19209009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.